We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia’s TGA Takes European Approach to Release of Commercially Confidential Information
Australia’s TGA Takes European Approach to Release of Commercially Confidential Information
Australian drug regulators have adopted their European counterparts’ definition of “commercially confidential information” — a move that is raising concerns among some drugmakers who contend that not enough consultation takes place with manufacturers to ascertain what constitutes CCI prior to its disclosure.